Nature communications · 2026
Latent transition analysis for longitudinal studies of post-acute infection syndromes.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Gusinow Roy, Górska Anna, Canziani Lorenzo Maria, Lopes-Rafegas Iris, Alvarez Garavito Carolina, Tami Adriana, Gentilotti Elisa, Sicuri Elisa, Laouénan Cédric, Ghosn Jade, Florence Aline-Marie, Lahfej Nadhem, Mazzaferri Fulvia, Del Piccolo Lidia, Giannella Maddalena, Toschi Alice, Di Chiara Michela, Caponcello Maria Giulia, Palacios-Baena Zaira R, Wold Karin I, Rossi Elisa, Tacconelli Evelina, Hasenauer Jan, ORCHESTRA study group
Аннотация
Post-Acute Infectious Syndromes (PAIS) refer to the symptoms persisting months after initial infection. Clinical research studies on this topic often collect rich, multi-modal datasets. Yet, the complexity of the datasets and the lack of a precise clinical case definition pose difficulties in creating comprehensive analyses. Here, we present a generalisable framework for analysing data from longitudinal studies of PAIS using Latent Transition Analysis (LTA). It enables the identification of disease phenotypes and the patient-level analysis of transitions between them, without relying on predefined clinical categorisations. Furthermore, we introduce a method for incorporating covariate information, which enables exploration of how patient characteristics influence disease trajectories. We apply this methodology to the ORCHESTRA dataset, composed of individuals affected by SARS-CoV-2 infection from multiple European centres, for investigation into Post-COVID-19 condition (PCC). 5094 patient assessments were collected at SARS-CoV-2 infection, and at 6, 12, 18, and 24 months of follow-up. Our model identifies distinct PCC phenotypes with patient trajectories impacted by age and sex. Our results highlight how LTA can enhance the interpretability of complex, time-resolved clinical data, support personalized patient monitoring and management, and accelerate therapeutic development for other PAISs, too.